# Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis

> **NCT06700421** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Wei Zhou** · enrollment: 32 (estimated)

## Conditions studied

- Unresectable Locally Advanced Non-small Cell Lung Cancer

## Interventions

- **DRUG:** Adebrelimab + Apatinib

## Key facts

- **NCT ID:** NCT06700421
- **Lead sponsor:** Wei Zhou
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-08-13
- **Primary completion:** 2024-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-11-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06700421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06700421, "Phase II Clinical Study of Adebrelimab Combined with Apatinib in the Treatment of Locally Advanced Non-small Cell Lung Cancer Patients with Radiation Pneumonitis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06700421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*